The pursuit of market outperformance leads investors to the practice of hand-picking stocks. Skillful choices can be a catalyst for significant wealth enhancement.
The price of Axsome Therapeutics Inc (NASDAQ: AXSM) closed at $102.27 in the last session, up 6.33% from day before closing price of $96.18. In other words, the price has increased by $6.33 from its previous closing price. On the day, 1.24 million shares were traded. AXSM stock price reached its highest trading level at $102.74 during the session, while it also had its lowest trading level at $95.41.
Ratios:
We take a closer look at AXSM’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 2.37 and its Current Ratio is at 2.44. In the meantime, Its Debt-to-Equity ratio is 2.07 whereas as Long-Term Debt/Eq ratio is at 2.04.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Mizuho on December 31, 2024, Reiterated its Outperform rating but revised its target price to $122 from $124 previously.
On September 03, 2024, Wells Fargo started tracking the stock assigning a Overweight rating and target price of $140.
BofA Securities Upgraded its Neutral to Buy on August 06, 2024, whereas the target price for the stock was revised from $95 to $106.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Sep 11 ’24 when Saad Mark E sold 11,016 shares for $91.31 per share. The transaction valued at 1,005,871 led to the insider holds 10,002 shares of the business.
Saad Mark E bought 11,016 shares of AXSM for $1,005,843 on Sep 11 ’24. On Aug 09 ’24, another insider, Jacobson Mark L., who serves as the Chief Operating Officer of the company, sold 47,739 shares for $84.26 each. As a result, the insider received 4,022,488 and left with 5,783 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, AXSM now has a Market Capitalization of 4956249600 and an Enterprise Value of 4821206016. For the stock, the TTM Price-to-Sale (P/S) ratio is 14.64 while its Price-to-Book (P/B) ratio in mrq is 53.32. Its current Enterprise Value per Revenue stands at 14.245 whereas that against EBITDA is -19.709.
Stock Price History:
The Beta on a monthly basis for AXSM is 1.04, which has changed by 0.061706543 over the last 52 weeks, in comparison to a change of 0.24359846 over the same period for the S&P500. Over the past 52 weeks, AXSM has reached a high of $105.00, while it has fallen to a 52-week low of $64.11. The 50-Day Moving Average of the stock is 10.23%, while the 200-Day Moving Average is calculated to be 20.35%.
Shares Statistics:
According to the various share statistics, AXSM traded on average about 673.10K shares per day over the past 3-months and 1003540 shares per day over the past 10 days. A total of 48.44M shares are outstanding, with a floating share count of 39.60M. Insiders hold about 18.28% of the company’s shares, while institutions hold 79.22% stake in the company. Shares short for AXSM as of 1735603200 were 6619135 with a Short Ratio of 9.83, compared to 1732838400 on 7075616. Therefore, it implies a Short% of Shares Outstanding of 6619135 and a Short% of Float of 16.360001.
